User login
Estimating Hospital Costs of CAUTI
Healthcare‐associated infections affect 5% to 10% of all hospitalized patients each year in the United States, account for nearly $45 billion in direct hospital costs, and cause nearly 100,000 deaths annually.[1, 2] Because catheter‐associated urinary tract infection (CAUTI) is one of the most common healthcare‐associated infections in the United States and is reasonably preventable, the Centers for Medicare and Medicaid Services stopped reimbursing hospitals in 2008 for the additional costs of caring for patients who develop CAUTI during hospitalization.[3] Still, strategies for reducing inappropriate urinary catheterization are infrequently implemented in practice; this is despite a consensus that such strategies are effective.[4]
To help motivate hospitals to reduce inappropriate urinary catheter use, we present a tool for estimating costs of CAUTI for individual hospitals. Although other tools for estimating the excess costs of healthcare‐associated infections are available (eg, the APIC Cost of Healthcare‐Associated Infections Model available at
METHODS
General Setup
We consider 4 possible events after urinary catheter placement: bacteriuria, symptomatic urinary tract infection (SUTI), bloodstream infection (BSI), and catheter removal. Conservatively, assuming that bacteriuria must precede SUTI and BSI, there are 5 possible trajectories for any hospitalized patient (Figure 1): (1) no infection, (2) only bacteriuria, (3) bacteriuria and SUTI, (4) bacteriuria and BSI, or (5) bacteriuria, SUTI, and BSI. The cost of CAUTI for a particular hospital is therefore the per‐patient cost of each trajectory multiplied by the number of patients experiencing each trajectory. Our approach for estimating hospital costs is based on factorizing the number of patients experiencing each trajectory into a product of terms for which estimates are available from the literature (see the Supporting Information, Appendix, in the online version of this article for all technical details).
Deriving Estimates of Current Costs
We start with 2 minor simplifying assumptions. First, because the presence of asymptomatic bacteriuria is typically unknown, we only consider costs to the hospital due to SUTI and BSI[6]; in other words, we assume hospitals do not incur costs for patients with trajectories 1 or 2. This assumption should only bias cost estimates conservatively. Second, we assume that patients with both SUTI and BSI (trajectory 5) incur costs equal to those for patients with only BSI (trajectory 4). Further, because the joint risk of SUTI and BSI is unknown, we conservatively assume SUTI must precede BSI. Under these assumptions we can write: (total CAUTI costs)=(per‐patient SUTI cost) (number with SUTI but no BSI)+(perpatient BSI cost) (number with BSI).
We use per‐patient hospital costs of SUTI and BSI of $911 and $3824, respectively, which were determined using a microcosting approach[6] and adjusted for inflation using the general Consumer Price Index.[7] Although an alternative strategy for estimating costs would be to enter the hospital‐specific, per‐patient costs of SUTI and BSI into the above equation, these quantities are often difficult to measure or otherwise unavailable. Thus, it remains to factorize the number of hospitalized patients who develop SUTI and BSI into component terms for which we have accessible estimates. First note that the number with only SUTI (or any BSI) equals the total number of patients hospitalized times the proportion of hospitalizations with only SUTI (or any BSI). The former quantity depends on the particular hospital and so is specified as an input by the user. The latter quantity can be factorized further under our aforementioned conservative assumption that bacteriuria must precede SUTI and BSI.
Specifically, for SUTI:
(Proportion SUTI but no BSI)={(SUTI risk among those catheterized with bacteriuria)(BSI risk among those catheterized with bacteriuria)} (bacteriuria risk among those catheterized) (proportion catheterized).
And for BSI:
(Proportion BSI)=(BSI risk among those catheterized with bacteriuria) (bacteriuria risk among those catheterized) (proportion catheterized).
The risks of SUTI and BSI among those catheterized with bacteriuria, along with the risk of bacteriuria among those catheterized, have been estimated previously via a meta‐analytic approach.[6] The proportion catheterized depends on the particular hospital, such as the total number of patients hospitalized, and so is also specified as a user input. Therefore, we have now factorized the total hospital costs due to CAUTI as a product of either user‐specified terms or terms for which we have estimates from the literature. All estimates and corresponding standard errors derived from the literature are listed together in Table 1 (see the Supporting Information, Appendix Section 1, for further details in the online version of this article).
| Quantity | Estimate (SE) |
|---|---|
| |
| Overall risk of bacteriuria among those catheterized | 26.0% (1.53%) |
| Per‐day risk of bacteriuria among those catheterized | 5.0% |
| days | 6.68 |
| Risk of SUTI among those catheterized with bacteriuria | 24.0% (4.08%) |
| Risk of BSI among those catheterized with bacteriuria | 3.6% (0.10%) |
| Per‐patient SUTI cost | $911 ($911) |
| Per‐patient BSI cost | $3824 ($3824) |
Deriving Projected Costs After Intervention
The approach described above permits estimation of current costs for managing patients with CAUTI for a particular hospital. To estimate projected costs after participation in an intervention to reduce infection risk, we characterize interventions of interest and introduce additional factorization. Specifically, following previous work,[8] we consider interventions that reduce (1) placement (ie, the proportion catheterized) and (2) duration (ie, the mean duration of catheterization). Incorporating reductions in placement is straightforward, because our above expression for costs already contains a term for the proportion catheterized. However, incorporating reductions in duration requires further factorization. Under the assumptions of constant per‐day risks of bacteriuria and of catheter removal, we can write the postintervention risk of bacteriuria among the catheterized as a function of (1) the percent decrease in mean duration of catheterization due to intervention, and (2) the preintervention risk of bacteriuria among the catheterized (see the Supporting Information, Appendix Section 2, for further details in the online version of this article). This means we can fully characterize postintervention costs as a function of user‐specified quantities, quantities specific to the intervention (which are varied across plausible ranges), and quantities for which we have estimates from the literature. Therefore, we can estimate savings by subtracting postintervention costs from current costs.
Because our estimators of current costs, projected costs, and savings are all formulated as functions of other estimators, we use the standard delta method approach[9] to derive appropriate variance estimates (see the Supporting Information, Appendix Section 3, for further details in the online version of this article).
Online Implementation
Customized results (based on annual admissions, urinary catheter prevalence, and other inputs) can be computed using online implementation of our proposed method at
RESULTS
Figure 2 shows the projected savings in hospital costs due to CAUTI across a range of interventions defined by percent decreases in placement and duration, for a hypothetical hospital with 3000 total patients, 15% with urinary catheters preintervention, and with all other default values listed in Table 1. The current costs for this hospital (ie, the costs when the percent reduction in placement and duration is zero) are estimated to be $37,868 (95% confidence interval [CI]: $9159‐$156,564). After an intervention resulting in 40% reductions in both urinary catheter placement and duration, this hospital would be expected to save $22,653 (95% CI: $5479‐$93,656). A less effective intervention yielding a 10% reduction in both urinary catheter placement and duration would result in more modest savings of $6376 (95% CI: $1542‐$26,360).
After an intervention resulting in 29% and 37% reductions in placement and duration, respectively, reflecting reductions seen in practice,[10, 11] our hypothetical hospital is estimated to save $19,126 (95% CI: $4626‐$79,074). This reflects an estimated savings of nearly 50%.
DISCUSSION
We have presented a tool for estimating customized hospital costs of CAUTI, both before and after a hypothetical intervention to reduce risk of infection. Our approach relies on mostly conservative assumptions, incorporates published risk estimates (properly accounting for their associated variability), and has easy‐to‐use online implementation. We believe this can play an important role in motivating hospitals to reduce inappropriate urinary catheter use.
The methodology employed here does have a few limitations. First and foremost, our results depend on the reliability of the input values, which are either provided by users or are based on estimates from the literature (see Table 1 for a complete list of suggested defaults). New information could potentially be incorporated if and when available. For example, substitution of more precise risk estimates could help reduce confidence interval length. Second, our approach essentially averages over hospital quality; we do not directly take into account quality of care or variation in underlying infection risk across hospitals in computing estimated costs. Finally, we only compute direct costs due to infection; other costs (eg, intervention costs) would typically also need to be considered for decision making.
Despite these limitations, we believe that our tool can help infection control professionals demonstrate the values of CAUTI prevention efforts to key administrators, particularly at a time where it has become increasingly necessary to develop a business case to initiate new interventions or justify the continued support for ongoing programs.[12] Additionally, we believe the proposed approach can be an important supplement to initiatives like the Society of Hospital Medicine's Choosing Wisely campaign, which aims to help reduce inappropriate urinary catheter use. Reducing catheter utilization has the potential to reduce costs associated with caring for CAUTI patients, but more importantly would help reduce CAUTI incidence as well as catheter‐related, noninfectious complications.[13, 14] We hope that our tool will greatly assist hospitals in promoting their CAUTI prevention efforts and improve the overall safety of hospitalized patients.
Disclosures
This project was supported by the Ann Arbor VA Medical Center/University of Michigan Patient Safety Enhancement Program (PSEP) and a subcontract to implement multistate CAUTI prevention with the Agency for Healthcare Research and Quality/Health Educational and Research Trust. Mr. Kennedy has no conflicts of interest to report. Drs. Saint and Greene are subcontracted to implement multistate CAUTI prevention with the Agency for Healthcare Research and Quality/Health Educational and Research Trust. Dr. Saint has received numerous honoraria and speaking fees for lectures on healthcare‐associated infection prevention, implementation science, and patient safety from hospitals, academic medical centers, professional societies, and nonprofit foundations. None of these activities are related to speaker's bureaus. Dr. Saint is also on the medical advisory board of Doximity, a new social networking site for physicians. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.
- , , , et al. Estimating health care‐associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–166.
- The direct medical costs of healthcare‐associated infections in US hospitals and the benefits of prevention. US Centers for Disease Control and Prevention Web site. Published 2009. Available at: http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf. Accessed March 24, 2013.
- , , , , . Catheter‐associated urinary tract infection and the Medicare rule changes. Ann Intern Med. 2009;150(12):877–884.
- , . Improving use of the other catheter. Arch Intern Med. 2012;172(3):260–261.
- Choosing Wisely: five things patients and physicians should question. Society of Hospital Medicine. Published 2012. Available at: http://www.hospitalmedicine.org/AM/pdf/SHM‐Adult_5things_List_Web.pdf. Accessed March 24, 2013.
- . Clinical and economic consequences of nosocomial catheter‐related bacteriuria. Am J Infect Control. 2000;28(1):68–75.
- CPI Inflation Calculator. United States Department of Labor, Bureau of Labor Statistics Web site. Published 2013. Available at: http://www.bls.gov/data/inflation_calculator.htm. Accessed March 24, 2013.
- , , , et al. Introducing a population‐based outcome measure to evaluate the effect of interventions to reduce catheter‐associated urinary tract infection. Am J Infect Control. 2012;40(4):359–364.
- . Asymptotic Statistics. Cambridge, UK: Cambridge University Press; 2000.
- , , , et al. Effect of establishing guidelines on appropriate urinary catheter placement. Acad Emerg Med. 2010;17:337–340.
- , , , . Systematic review and meta‐analysis: reminder systems to reduce catheter‐associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis. 2010;51(5):550–560.
- , , , et al. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol. 2007;28:1121–1133.
- , , , , . Urinary catheters: what type do men and their nurses prefer? J Am Geriatr Soc. 1999;47(12):1453–1457.
- , , . Indwelling urinary catheters: a one‐point restraint? Ann Intern Med. 2002;137(2):125–127.
Healthcare‐associated infections affect 5% to 10% of all hospitalized patients each year in the United States, account for nearly $45 billion in direct hospital costs, and cause nearly 100,000 deaths annually.[1, 2] Because catheter‐associated urinary tract infection (CAUTI) is one of the most common healthcare‐associated infections in the United States and is reasonably preventable, the Centers for Medicare and Medicaid Services stopped reimbursing hospitals in 2008 for the additional costs of caring for patients who develop CAUTI during hospitalization.[3] Still, strategies for reducing inappropriate urinary catheterization are infrequently implemented in practice; this is despite a consensus that such strategies are effective.[4]
To help motivate hospitals to reduce inappropriate urinary catheter use, we present a tool for estimating costs of CAUTI for individual hospitals. Although other tools for estimating the excess costs of healthcare‐associated infections are available (eg, the APIC Cost of Healthcare‐Associated Infections Model available at
METHODS
General Setup
We consider 4 possible events after urinary catheter placement: bacteriuria, symptomatic urinary tract infection (SUTI), bloodstream infection (BSI), and catheter removal. Conservatively, assuming that bacteriuria must precede SUTI and BSI, there are 5 possible trajectories for any hospitalized patient (Figure 1): (1) no infection, (2) only bacteriuria, (3) bacteriuria and SUTI, (4) bacteriuria and BSI, or (5) bacteriuria, SUTI, and BSI. The cost of CAUTI for a particular hospital is therefore the per‐patient cost of each trajectory multiplied by the number of patients experiencing each trajectory. Our approach for estimating hospital costs is based on factorizing the number of patients experiencing each trajectory into a product of terms for which estimates are available from the literature (see the Supporting Information, Appendix, in the online version of this article for all technical details).
Deriving Estimates of Current Costs
We start with 2 minor simplifying assumptions. First, because the presence of asymptomatic bacteriuria is typically unknown, we only consider costs to the hospital due to SUTI and BSI[6]; in other words, we assume hospitals do not incur costs for patients with trajectories 1 or 2. This assumption should only bias cost estimates conservatively. Second, we assume that patients with both SUTI and BSI (trajectory 5) incur costs equal to those for patients with only BSI (trajectory 4). Further, because the joint risk of SUTI and BSI is unknown, we conservatively assume SUTI must precede BSI. Under these assumptions we can write: (total CAUTI costs)=(per‐patient SUTI cost) (number with SUTI but no BSI)+(perpatient BSI cost) (number with BSI).
We use per‐patient hospital costs of SUTI and BSI of $911 and $3824, respectively, which were determined using a microcosting approach[6] and adjusted for inflation using the general Consumer Price Index.[7] Although an alternative strategy for estimating costs would be to enter the hospital‐specific, per‐patient costs of SUTI and BSI into the above equation, these quantities are often difficult to measure or otherwise unavailable. Thus, it remains to factorize the number of hospitalized patients who develop SUTI and BSI into component terms for which we have accessible estimates. First note that the number with only SUTI (or any BSI) equals the total number of patients hospitalized times the proportion of hospitalizations with only SUTI (or any BSI). The former quantity depends on the particular hospital and so is specified as an input by the user. The latter quantity can be factorized further under our aforementioned conservative assumption that bacteriuria must precede SUTI and BSI.
Specifically, for SUTI:
(Proportion SUTI but no BSI)={(SUTI risk among those catheterized with bacteriuria)(BSI risk among those catheterized with bacteriuria)} (bacteriuria risk among those catheterized) (proportion catheterized).
And for BSI:
(Proportion BSI)=(BSI risk among those catheterized with bacteriuria) (bacteriuria risk among those catheterized) (proportion catheterized).
The risks of SUTI and BSI among those catheterized with bacteriuria, along with the risk of bacteriuria among those catheterized, have been estimated previously via a meta‐analytic approach.[6] The proportion catheterized depends on the particular hospital, such as the total number of patients hospitalized, and so is also specified as a user input. Therefore, we have now factorized the total hospital costs due to CAUTI as a product of either user‐specified terms or terms for which we have estimates from the literature. All estimates and corresponding standard errors derived from the literature are listed together in Table 1 (see the Supporting Information, Appendix Section 1, for further details in the online version of this article).
| Quantity | Estimate (SE) |
|---|---|
| |
| Overall risk of bacteriuria among those catheterized | 26.0% (1.53%) |
| Per‐day risk of bacteriuria among those catheterized | 5.0% |
| days | 6.68 |
| Risk of SUTI among those catheterized with bacteriuria | 24.0% (4.08%) |
| Risk of BSI among those catheterized with bacteriuria | 3.6% (0.10%) |
| Per‐patient SUTI cost | $911 ($911) |
| Per‐patient BSI cost | $3824 ($3824) |
Deriving Projected Costs After Intervention
The approach described above permits estimation of current costs for managing patients with CAUTI for a particular hospital. To estimate projected costs after participation in an intervention to reduce infection risk, we characterize interventions of interest and introduce additional factorization. Specifically, following previous work,[8] we consider interventions that reduce (1) placement (ie, the proportion catheterized) and (2) duration (ie, the mean duration of catheterization). Incorporating reductions in placement is straightforward, because our above expression for costs already contains a term for the proportion catheterized. However, incorporating reductions in duration requires further factorization. Under the assumptions of constant per‐day risks of bacteriuria and of catheter removal, we can write the postintervention risk of bacteriuria among the catheterized as a function of (1) the percent decrease in mean duration of catheterization due to intervention, and (2) the preintervention risk of bacteriuria among the catheterized (see the Supporting Information, Appendix Section 2, for further details in the online version of this article). This means we can fully characterize postintervention costs as a function of user‐specified quantities, quantities specific to the intervention (which are varied across plausible ranges), and quantities for which we have estimates from the literature. Therefore, we can estimate savings by subtracting postintervention costs from current costs.
Because our estimators of current costs, projected costs, and savings are all formulated as functions of other estimators, we use the standard delta method approach[9] to derive appropriate variance estimates (see the Supporting Information, Appendix Section 3, for further details in the online version of this article).
Online Implementation
Customized results (based on annual admissions, urinary catheter prevalence, and other inputs) can be computed using online implementation of our proposed method at
RESULTS
Figure 2 shows the projected savings in hospital costs due to CAUTI across a range of interventions defined by percent decreases in placement and duration, for a hypothetical hospital with 3000 total patients, 15% with urinary catheters preintervention, and with all other default values listed in Table 1. The current costs for this hospital (ie, the costs when the percent reduction in placement and duration is zero) are estimated to be $37,868 (95% confidence interval [CI]: $9159‐$156,564). After an intervention resulting in 40% reductions in both urinary catheter placement and duration, this hospital would be expected to save $22,653 (95% CI: $5479‐$93,656). A less effective intervention yielding a 10% reduction in both urinary catheter placement and duration would result in more modest savings of $6376 (95% CI: $1542‐$26,360).
After an intervention resulting in 29% and 37% reductions in placement and duration, respectively, reflecting reductions seen in practice,[10, 11] our hypothetical hospital is estimated to save $19,126 (95% CI: $4626‐$79,074). This reflects an estimated savings of nearly 50%.
DISCUSSION
We have presented a tool for estimating customized hospital costs of CAUTI, both before and after a hypothetical intervention to reduce risk of infection. Our approach relies on mostly conservative assumptions, incorporates published risk estimates (properly accounting for their associated variability), and has easy‐to‐use online implementation. We believe this can play an important role in motivating hospitals to reduce inappropriate urinary catheter use.
The methodology employed here does have a few limitations. First and foremost, our results depend on the reliability of the input values, which are either provided by users or are based on estimates from the literature (see Table 1 for a complete list of suggested defaults). New information could potentially be incorporated if and when available. For example, substitution of more precise risk estimates could help reduce confidence interval length. Second, our approach essentially averages over hospital quality; we do not directly take into account quality of care or variation in underlying infection risk across hospitals in computing estimated costs. Finally, we only compute direct costs due to infection; other costs (eg, intervention costs) would typically also need to be considered for decision making.
Despite these limitations, we believe that our tool can help infection control professionals demonstrate the values of CAUTI prevention efforts to key administrators, particularly at a time where it has become increasingly necessary to develop a business case to initiate new interventions or justify the continued support for ongoing programs.[12] Additionally, we believe the proposed approach can be an important supplement to initiatives like the Society of Hospital Medicine's Choosing Wisely campaign, which aims to help reduce inappropriate urinary catheter use. Reducing catheter utilization has the potential to reduce costs associated with caring for CAUTI patients, but more importantly would help reduce CAUTI incidence as well as catheter‐related, noninfectious complications.[13, 14] We hope that our tool will greatly assist hospitals in promoting their CAUTI prevention efforts and improve the overall safety of hospitalized patients.
Disclosures
This project was supported by the Ann Arbor VA Medical Center/University of Michigan Patient Safety Enhancement Program (PSEP) and a subcontract to implement multistate CAUTI prevention with the Agency for Healthcare Research and Quality/Health Educational and Research Trust. Mr. Kennedy has no conflicts of interest to report. Drs. Saint and Greene are subcontracted to implement multistate CAUTI prevention with the Agency for Healthcare Research and Quality/Health Educational and Research Trust. Dr. Saint has received numerous honoraria and speaking fees for lectures on healthcare‐associated infection prevention, implementation science, and patient safety from hospitals, academic medical centers, professional societies, and nonprofit foundations. None of these activities are related to speaker's bureaus. Dr. Saint is also on the medical advisory board of Doximity, a new social networking site for physicians. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.
Healthcare‐associated infections affect 5% to 10% of all hospitalized patients each year in the United States, account for nearly $45 billion in direct hospital costs, and cause nearly 100,000 deaths annually.[1, 2] Because catheter‐associated urinary tract infection (CAUTI) is one of the most common healthcare‐associated infections in the United States and is reasonably preventable, the Centers for Medicare and Medicaid Services stopped reimbursing hospitals in 2008 for the additional costs of caring for patients who develop CAUTI during hospitalization.[3] Still, strategies for reducing inappropriate urinary catheterization are infrequently implemented in practice; this is despite a consensus that such strategies are effective.[4]
To help motivate hospitals to reduce inappropriate urinary catheter use, we present a tool for estimating costs of CAUTI for individual hospitals. Although other tools for estimating the excess costs of healthcare‐associated infections are available (eg, the APIC Cost of Healthcare‐Associated Infections Model available at
METHODS
General Setup
We consider 4 possible events after urinary catheter placement: bacteriuria, symptomatic urinary tract infection (SUTI), bloodstream infection (BSI), and catheter removal. Conservatively, assuming that bacteriuria must precede SUTI and BSI, there are 5 possible trajectories for any hospitalized patient (Figure 1): (1) no infection, (2) only bacteriuria, (3) bacteriuria and SUTI, (4) bacteriuria and BSI, or (5) bacteriuria, SUTI, and BSI. The cost of CAUTI for a particular hospital is therefore the per‐patient cost of each trajectory multiplied by the number of patients experiencing each trajectory. Our approach for estimating hospital costs is based on factorizing the number of patients experiencing each trajectory into a product of terms for which estimates are available from the literature (see the Supporting Information, Appendix, in the online version of this article for all technical details).
Deriving Estimates of Current Costs
We start with 2 minor simplifying assumptions. First, because the presence of asymptomatic bacteriuria is typically unknown, we only consider costs to the hospital due to SUTI and BSI[6]; in other words, we assume hospitals do not incur costs for patients with trajectories 1 or 2. This assumption should only bias cost estimates conservatively. Second, we assume that patients with both SUTI and BSI (trajectory 5) incur costs equal to those for patients with only BSI (trajectory 4). Further, because the joint risk of SUTI and BSI is unknown, we conservatively assume SUTI must precede BSI. Under these assumptions we can write: (total CAUTI costs)=(per‐patient SUTI cost) (number with SUTI but no BSI)+(perpatient BSI cost) (number with BSI).
We use per‐patient hospital costs of SUTI and BSI of $911 and $3824, respectively, which were determined using a microcosting approach[6] and adjusted for inflation using the general Consumer Price Index.[7] Although an alternative strategy for estimating costs would be to enter the hospital‐specific, per‐patient costs of SUTI and BSI into the above equation, these quantities are often difficult to measure or otherwise unavailable. Thus, it remains to factorize the number of hospitalized patients who develop SUTI and BSI into component terms for which we have accessible estimates. First note that the number with only SUTI (or any BSI) equals the total number of patients hospitalized times the proportion of hospitalizations with only SUTI (or any BSI). The former quantity depends on the particular hospital and so is specified as an input by the user. The latter quantity can be factorized further under our aforementioned conservative assumption that bacteriuria must precede SUTI and BSI.
Specifically, for SUTI:
(Proportion SUTI but no BSI)={(SUTI risk among those catheterized with bacteriuria)(BSI risk among those catheterized with bacteriuria)} (bacteriuria risk among those catheterized) (proportion catheterized).
And for BSI:
(Proportion BSI)=(BSI risk among those catheterized with bacteriuria) (bacteriuria risk among those catheterized) (proportion catheterized).
The risks of SUTI and BSI among those catheterized with bacteriuria, along with the risk of bacteriuria among those catheterized, have been estimated previously via a meta‐analytic approach.[6] The proportion catheterized depends on the particular hospital, such as the total number of patients hospitalized, and so is also specified as a user input. Therefore, we have now factorized the total hospital costs due to CAUTI as a product of either user‐specified terms or terms for which we have estimates from the literature. All estimates and corresponding standard errors derived from the literature are listed together in Table 1 (see the Supporting Information, Appendix Section 1, for further details in the online version of this article).
| Quantity | Estimate (SE) |
|---|---|
| |
| Overall risk of bacteriuria among those catheterized | 26.0% (1.53%) |
| Per‐day risk of bacteriuria among those catheterized | 5.0% |
| days | 6.68 |
| Risk of SUTI among those catheterized with bacteriuria | 24.0% (4.08%) |
| Risk of BSI among those catheterized with bacteriuria | 3.6% (0.10%) |
| Per‐patient SUTI cost | $911 ($911) |
| Per‐patient BSI cost | $3824 ($3824) |
Deriving Projected Costs After Intervention
The approach described above permits estimation of current costs for managing patients with CAUTI for a particular hospital. To estimate projected costs after participation in an intervention to reduce infection risk, we characterize interventions of interest and introduce additional factorization. Specifically, following previous work,[8] we consider interventions that reduce (1) placement (ie, the proportion catheterized) and (2) duration (ie, the mean duration of catheterization). Incorporating reductions in placement is straightforward, because our above expression for costs already contains a term for the proportion catheterized. However, incorporating reductions in duration requires further factorization. Under the assumptions of constant per‐day risks of bacteriuria and of catheter removal, we can write the postintervention risk of bacteriuria among the catheterized as a function of (1) the percent decrease in mean duration of catheterization due to intervention, and (2) the preintervention risk of bacteriuria among the catheterized (see the Supporting Information, Appendix Section 2, for further details in the online version of this article). This means we can fully characterize postintervention costs as a function of user‐specified quantities, quantities specific to the intervention (which are varied across plausible ranges), and quantities for which we have estimates from the literature. Therefore, we can estimate savings by subtracting postintervention costs from current costs.
Because our estimators of current costs, projected costs, and savings are all formulated as functions of other estimators, we use the standard delta method approach[9] to derive appropriate variance estimates (see the Supporting Information, Appendix Section 3, for further details in the online version of this article).
Online Implementation
Customized results (based on annual admissions, urinary catheter prevalence, and other inputs) can be computed using online implementation of our proposed method at
RESULTS
Figure 2 shows the projected savings in hospital costs due to CAUTI across a range of interventions defined by percent decreases in placement and duration, for a hypothetical hospital with 3000 total patients, 15% with urinary catheters preintervention, and with all other default values listed in Table 1. The current costs for this hospital (ie, the costs when the percent reduction in placement and duration is zero) are estimated to be $37,868 (95% confidence interval [CI]: $9159‐$156,564). After an intervention resulting in 40% reductions in both urinary catheter placement and duration, this hospital would be expected to save $22,653 (95% CI: $5479‐$93,656). A less effective intervention yielding a 10% reduction in both urinary catheter placement and duration would result in more modest savings of $6376 (95% CI: $1542‐$26,360).
After an intervention resulting in 29% and 37% reductions in placement and duration, respectively, reflecting reductions seen in practice,[10, 11] our hypothetical hospital is estimated to save $19,126 (95% CI: $4626‐$79,074). This reflects an estimated savings of nearly 50%.
DISCUSSION
We have presented a tool for estimating customized hospital costs of CAUTI, both before and after a hypothetical intervention to reduce risk of infection. Our approach relies on mostly conservative assumptions, incorporates published risk estimates (properly accounting for their associated variability), and has easy‐to‐use online implementation. We believe this can play an important role in motivating hospitals to reduce inappropriate urinary catheter use.
The methodology employed here does have a few limitations. First and foremost, our results depend on the reliability of the input values, which are either provided by users or are based on estimates from the literature (see Table 1 for a complete list of suggested defaults). New information could potentially be incorporated if and when available. For example, substitution of more precise risk estimates could help reduce confidence interval length. Second, our approach essentially averages over hospital quality; we do not directly take into account quality of care or variation in underlying infection risk across hospitals in computing estimated costs. Finally, we only compute direct costs due to infection; other costs (eg, intervention costs) would typically also need to be considered for decision making.
Despite these limitations, we believe that our tool can help infection control professionals demonstrate the values of CAUTI prevention efforts to key administrators, particularly at a time where it has become increasingly necessary to develop a business case to initiate new interventions or justify the continued support for ongoing programs.[12] Additionally, we believe the proposed approach can be an important supplement to initiatives like the Society of Hospital Medicine's Choosing Wisely campaign, which aims to help reduce inappropriate urinary catheter use. Reducing catheter utilization has the potential to reduce costs associated with caring for CAUTI patients, but more importantly would help reduce CAUTI incidence as well as catheter‐related, noninfectious complications.[13, 14] We hope that our tool will greatly assist hospitals in promoting their CAUTI prevention efforts and improve the overall safety of hospitalized patients.
Disclosures
This project was supported by the Ann Arbor VA Medical Center/University of Michigan Patient Safety Enhancement Program (PSEP) and a subcontract to implement multistate CAUTI prevention with the Agency for Healthcare Research and Quality/Health Educational and Research Trust. Mr. Kennedy has no conflicts of interest to report. Drs. Saint and Greene are subcontracted to implement multistate CAUTI prevention with the Agency for Healthcare Research and Quality/Health Educational and Research Trust. Dr. Saint has received numerous honoraria and speaking fees for lectures on healthcare‐associated infection prevention, implementation science, and patient safety from hospitals, academic medical centers, professional societies, and nonprofit foundations. None of these activities are related to speaker's bureaus. Dr. Saint is also on the medical advisory board of Doximity, a new social networking site for physicians. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.
- , , , et al. Estimating health care‐associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–166.
- The direct medical costs of healthcare‐associated infections in US hospitals and the benefits of prevention. US Centers for Disease Control and Prevention Web site. Published 2009. Available at: http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf. Accessed March 24, 2013.
- , , , , . Catheter‐associated urinary tract infection and the Medicare rule changes. Ann Intern Med. 2009;150(12):877–884.
- , . Improving use of the other catheter. Arch Intern Med. 2012;172(3):260–261.
- Choosing Wisely: five things patients and physicians should question. Society of Hospital Medicine. Published 2012. Available at: http://www.hospitalmedicine.org/AM/pdf/SHM‐Adult_5things_List_Web.pdf. Accessed March 24, 2013.
- . Clinical and economic consequences of nosocomial catheter‐related bacteriuria. Am J Infect Control. 2000;28(1):68–75.
- CPI Inflation Calculator. United States Department of Labor, Bureau of Labor Statistics Web site. Published 2013. Available at: http://www.bls.gov/data/inflation_calculator.htm. Accessed March 24, 2013.
- , , , et al. Introducing a population‐based outcome measure to evaluate the effect of interventions to reduce catheter‐associated urinary tract infection. Am J Infect Control. 2012;40(4):359–364.
- . Asymptotic Statistics. Cambridge, UK: Cambridge University Press; 2000.
- , , , et al. Effect of establishing guidelines on appropriate urinary catheter placement. Acad Emerg Med. 2010;17:337–340.
- , , , . Systematic review and meta‐analysis: reminder systems to reduce catheter‐associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis. 2010;51(5):550–560.
- , , , et al. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol. 2007;28:1121–1133.
- , , , , . Urinary catheters: what type do men and their nurses prefer? J Am Geriatr Soc. 1999;47(12):1453–1457.
- , , . Indwelling urinary catheters: a one‐point restraint? Ann Intern Med. 2002;137(2):125–127.
- , , , et al. Estimating health care‐associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–166.
- The direct medical costs of healthcare‐associated infections in US hospitals and the benefits of prevention. US Centers for Disease Control and Prevention Web site. Published 2009. Available at: http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf. Accessed March 24, 2013.
- , , , , . Catheter‐associated urinary tract infection and the Medicare rule changes. Ann Intern Med. 2009;150(12):877–884.
- , . Improving use of the other catheter. Arch Intern Med. 2012;172(3):260–261.
- Choosing Wisely: five things patients and physicians should question. Society of Hospital Medicine. Published 2012. Available at: http://www.hospitalmedicine.org/AM/pdf/SHM‐Adult_5things_List_Web.pdf. Accessed March 24, 2013.
- . Clinical and economic consequences of nosocomial catheter‐related bacteriuria. Am J Infect Control. 2000;28(1):68–75.
- CPI Inflation Calculator. United States Department of Labor, Bureau of Labor Statistics Web site. Published 2013. Available at: http://www.bls.gov/data/inflation_calculator.htm. Accessed March 24, 2013.
- , , , et al. Introducing a population‐based outcome measure to evaluate the effect of interventions to reduce catheter‐associated urinary tract infection. Am J Infect Control. 2012;40(4):359–364.
- . Asymptotic Statistics. Cambridge, UK: Cambridge University Press; 2000.
- , , , et al. Effect of establishing guidelines on appropriate urinary catheter placement. Acad Emerg Med. 2010;17:337–340.
- , , , . Systematic review and meta‐analysis: reminder systems to reduce catheter‐associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis. 2010;51(5):550–560.
- , , , et al. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol. 2007;28:1121–1133.
- , , , , . Urinary catheters: what type do men and their nurses prefer? J Am Geriatr Soc. 1999;47(12):1453–1457.
- , , . Indwelling urinary catheters: a one‐point restraint? Ann Intern Med. 2002;137(2):125–127.
